COM:CVENT

National Comprehensive Cancer Network (NCCN)

Stock

Last Close

8.52

14/06 20:00

Market Cap

4.19B

Beta: -

Volume Today

12.22M

Avg: -

Overview Analysis Financials Filings people API Chart Data

Income Statement Balance Sheet Cash Flow Key Metrics Ratios

Quarterly

Yearly

Preview

Full access to financials is available to subscribers only. Please support our work and get full access to all features. You can cancel anytime. If you'd like a demo, free trial or have any questions, please checkout the help page

Subscribe Now Help

	Dec '18	Dec '19	Dec '20	Dec '21	Dec '22
net income	-54.04M -	-91.76M 69.80%	-83.73M 8.75%	-86.08M 2.80%	-100.27M 16.49%
depreciation and amortization	108.57M -	129.12M 18.92%	138.10M 6.96%	132.71M 3.91%	130.11M 1.96%
deferred income tax	-26.13M -	-12.30M 52.94%	2.02M 116.39%	-596K 129.56%	1.22M 303.86%
stock based compensation	17.91M -	18.83M 5.15%	17.70M 6.04%	25.06M 41.60%	65.08M 159.73%
change in working capital	-23.90M -	-26.79M 12.08%	-90.88M 239.28%	2.59M 102.85%	-9.95M 483.91%
accounts receivables	-33.12M -	-23.41M 29.32%	786K 103.36%	19.97M 2,440.20%	-10.21M 151.16%
inventory	3.39M -	-43.28M 1,377.13%	-38.64M 10.72%	-52.37M 35.51%
accounts payables	-3.65M -	-2.45M 32.75%	-36.43M 1,385.85%	1.96M 105.38%	16.46M 739.16%
other working capital	9.48M -	42.36M 346.79%	-16.59M 139.17%	33.03M 299.08%	-16.19M 149.01%
other non cash items	27.36M -	30.92M 13.02%	45.90M 48.43%	48.51M 5.70%	37.95M 21.78%
net cash provided by operating activities	49.77M -	48.03M 3.50%	29.10M 39.41%	122.20M 319.93%	124.14M 1.59%
investments in property plant and equipment	-48.70M -	-64.89M 33.25%	-42.65M 34.27%	-45.65M 7.03%	-57.96M 26.96%
acquisitions net	-121.69M -	-16.73M 86.25%	-900K 94.62%	-14.65M 1,527.44%	-3.44M 76.49%
purchases of investments	-28.38M -	-27.76M 2.17%	-26.92M 3.03%	-35.73M 32.72%	-93.23M 160.95%
sales maturities of investments	21.00M -	35.63M 69.69%	27.90M 21.69%	35.19M 26.12%	48.38M 37.49%
other investing activites
net cash used for investing activites	-177.77M -	-73.75M 58.51%	-42.57M 42.28%	-60.84M 42.91%	-106.26M 74.65%
debt repayment	-45.48M -	-7.93M 82.55%	-34.53M 335.22%	-519.35M 1,403.84%	-422.70M 18.61%
common stock issued					17.06M -
common stock repurchased		-253K -	-10K 96.05%	-230K 2,200%
dividends paid
other financing activites	131.69M -	28.54M 78.33%	40.07M 40.41%	522.46M 1,203.76%	365.79M 29.99%
net cash used provided by financing activities	86.20M -	20.35M 76.39%	5.53M 72.84%	2.87M 48.01%	-39.85M 1,486.64%
effect of forex changes on cash	1.03M -	255K 75.22%	693K 171.76%	-3.07M 543.43%	-4.73M 54.02%
net change in cash	-40.77M -	-5.12M 87.45%	-7.25M 41.68%	61.16M 943.46%	-26.71M 143.67%
cash at beginning of period	118.60M -	77.84M 34.37%	72.72M 6.58%	65.47M 9.97%	126.63M 93.42%
cash at end of period	77.84M -	72.72M 6.58%	65.47M 9.97%	126.63M 93.42%	99.92M 21.09%
operating cash flow	49.77M -	48.03M 3.50%	29.10M 39.41%	122.20M 319.93%	124.14M 1.59%
capital expenditure	-48.70M -	-64.89M 33.25%	-42.65M 34.27%	-45.65M 7.03%	-57.96M 26.96%
free cash flow	1.07M -	-16.86M 1,671.67%	-13.55M 19.63%	76.54M 664.73%	66.17M 13.55%

All numbers in (except ratios and percentages)